UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up

Annals of oncology, 2013-09, Vol.24 (9), p.2434-2438

2013

Volltextzugriff (PDF)

The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia

The pharmacogenomics journal, 2014-08, Vol.14 (4), p.328-335

2014

Volltextzugriff (PDF)

Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)

Annals of oncology, 2010-04, Vol.21 (4), p.851-854

2010

Volltextzugriff (PDF)

149 LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES

Leukemia research, 2015-04, Vol.39, p.S75-S75

2015

Volltextzugriff (PDF)

Cell clonality in hypereosinophilic syndrome: what pathogenetic role?

Clinical and experimental rheumatology, 2007-01, Vol.25 (1), p.17

2007

Volltextzugriff (PDF)

A rare case of primary systemic amyloidosis of the neck with massive cervical lymph node involvement: A case report and review of the literature

Leukemia research, 2010-04, Vol.34 (4), p.e100-e103

2010

Volltextzugriff (PDF)

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

Bone marrow transplantation (Basingstoke), 2003-07, Vol.32 (1), p.57-63

2003

Volltextzugriff (PDF)

Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib

European journal of clinical investigation, 2004-03, Vol.34 (3), p.243-244

2004

Volltextzugriff (PDF)

Role of Low-Dose 2-CdA in Refractory or Resistant Lymphoplasmocytic Lymphoma

Journal of chemotherapy (Florence), 2004-08, Vol.16 (4), p.388-391

2004

Volltextzugriff (PDF)

Recurrence of a 30-years old leukemic clone ten years after allogeneic transplant: Azacitidine and donor lymphocyte infusion are an effective strategy to restore the graft-versus leukemia effect

Journal of translational science, 2018, Vol.5 (6)

2018

Volltextzugriff (PDF)

Oral Cyclophosphamide Therapy for Patients with Residual or Relapsed Indolent-Type Lymphoma after Initial Treatment for Aggressive Lymphomas. A Sub-group of Patients with Apparent Transformed Indolent Lymphoma

Leukemia & lymphoma, 2002, Vol.43 (9), p.1803-1806

2002

Volltextzugriff (PDF)

Is lithium able to reverse neurological damage induced by vinca alkaloids?

Journal of Neural Transmission, 1999-01, Vol.106 (5-6), p.569-575

1999

Volltextzugriff (PDF)

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

European journal of haematology, 2004-12, Vol.73 (6), p.412-417

2004

Volltextzugriff (PDF)

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients

Biomedicine & pharmacotherapy, 2005-12, Vol.59 (10), p.541-544

2005

Volltextzugriff (PDF)

Imatinib therapy in Hypereosinophilic Syndrome: A case of molecular remission

Leukemia research, 2005-09, Vol.29 (9), p.1097-1098

2005

Volltextzugriff (PDF)

High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases

Clinical and experimental rheumatology, 2005-11, Vol.23 (6), p.877

2005

Volltextzugriff (PDF)

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi

Leukemia & lymphoma, 2006-03, Vol.47 (3), p.473-479

2006

Volltextzugriff (PDF)

Features of relapsed disease in lymphocyte predominant Hodgkin’s disease patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.6688-6688

2005

Volltextzugriff (PDF)

Efficacy and Toxicity of Liposomal Daunorubicin Included in PVABEC Regimen for Aggressive NHL of the Elderly

Leukemia & lymphoma, 2003-01, Vol.44 (3), p.465-469

2003

Volltextzugriff (PDF)

Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H)

Journal of immunotherapy (1997), 2004-09, Vol.27 (5), p.389-393

2004

Volltextzugriff (PDF)

THE EUROPEAN UNION - THE LEFT'S COMMITMENT

ITALIAN COMMUNISTS, 1987-01, Vol.1, p.25-28

Cervetti, G

1987

Volltextzugriff (PDF)

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

Cancer genetics and cytogenetics, 2005-10, Vol.162 (1), p.57-62

2005

Volltextzugriff (PDF)

Osteoid osteoma of the hallux

The Journal of foot surgery, 1987-09, Vol.26 (5), p.397

1987

Volltextzugriff (PDF)

Proposal for the treatment of cervix dysplasia with immunomodulators

Minerva ginecologica, 1992-01, Vol.44 (1-2), p.15

1992

Volltextzugriff (PDF)

The impact of an integrated approach to science and literacy in elementary school classrooms

Journal of research in science teaching, 2012-05, Vol.49 (5), p.631-658

2012

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Female
(26)
Middle Aged
(24)
Male
(23)
Adult
(20)
Aged
(18)
Oncology
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Treatment Outcome
(9)
Aged, 80 And Over
(8)
Hematology
(8)
Pharmacology. Drug Treatments
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Hematologic And Hematopoietic Diseases
(6)
Rituximab
(6)
Disease-Free Survival
(5)
Imatinib Mesylate
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up

The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia

Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)

149 LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES

Cell clonality in hypereosinophilic syndrome: what pathogenetic role?

A rare case of primary systemic amyloidosis of the neck with massive cervical lymph node involvement: A case report and review of the literature

Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab

Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib

Role of Low-Dose 2-CdA in Refractory or Resistant Lymphoplasmocytic Lymphoma

Recurrence of a 30-years old leukemic clone ten years after allogeneic transplant: Azacitidine and donor lymphocyte infusion are an effective strategy to restore the graft-versus leukemia effect

Oral Cyclophosphamide Therapy for Patients with Residual or Relapsed Indolent-Type Lymphoma after Initial Treatment for Aggressive Lymphomas. A Sub-group of Patients with Apparent Transformed Indolent Lymphoma

Is lithium able to reverse neurological damage induced by vinca alkaloids?

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients

Imatinib therapy in Hypereosinophilic Syndrome: A case of molecular remission

High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi

Features of relapsed disease in lymphocyte predominant Hodgkin’s disease patients

Efficacy and Toxicity of Liposomal Daunorubicin Included in PVABEC Regimen for Aggressive NHL of the Elderly

Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H)

THE EUROPEAN UNION - THE LEFT'S COMMITMENT

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment

Osteoid osteoma of the hallux

Proposal for the treatment of cervix dysplasia with immunomodulators

The impact of an integrated approach to science and literacy in elementary school classrooms

Suchergebnisse filtern